The CHA2DS2-VASc score is commonly employed for stroke risk stratification in AFib patients; combining it with EAT measurements could enhance predictive accuracy, as shown by Akdag et al. and Cosansu et al., who linked higher CHA2DS2-VASc scores with elevated EAT levels [18,37]. This evidence concerns the gene MCL1 and stroke disorder.